鉴定与万科米辛诱导的急性损伤相关的因素:使用共同数据模型进行回顾性分析
International journal of clinical pharmacology and therapeutics
|September 24, 2024
概括
潜在的病和ICU入院,而不是万科胺的水平,预测了万科胺诱导的急性损伤 (AKI). 这项研究使用了现实世界的数据来确定接受万科米的患者中AKI的关键风险因素.
科学领域:
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學.
- 临床信息学 临床信息学
背景情况:
- 范科米辛是治疗格拉姆阳性感染的关键抗生素.
- 在现有文献中,明素诱导的急性损伤 (AKI) 的预测因素仍然不一致.
- 观察医疗结果伙伴关系共同数据模型 (OMOP CDM) 提供了一种标准化的方法来分析现实世界的健康数据.
研究的目的:
- 为了确定香草素诱导的AKI的显著预测因子.
- 为了利用OMOPCDM进行电子健康记录的可靠分析.
- 为了澄清科米暴露和AKI发展之间的关联.
主要方法:
- 对116名患者进行了回顾性分析,这些患者因黄金葡萄球菌感染而接受了万科米治疗.
- 从2012年1月到2022年5月收集的数据,包括万科米辛度和基线肌素.
- 用于确定AKI预测器的赔率比率的物流回归模型.
主要成果:
- 高基线血清肌素,重症监护室 (ICU) 住院和并发性脏疾病与万科胺素诱导的AKI有显著的关联.
- 范科米辛的最低水平和曲线下的面积 (AUC) 并不是统计学上显著的预测指标,尽管在AKI患者中较高.
- 在第三次测量时,更高比例的AKI患者的最低水平> 20 mg/L.
结论:
- 潜在的脏疾病和ICU入院是香胺诱导的AKI的更强的预测因素,而不是药理动力学参数.
- 目前的临床实践可能涉及基于米素度的剂量,可能掩盖与AKI的直接PK/PD关系.
- 需要进一步的前性研究来验证这些发现,并为AKI预防策略提供信息.
相关概念视频
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
191
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
191
Factors Affecting Renal Clearance: Renal Impairment
61
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
61
Renal Failure: Dose Adjustments
68
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
68
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
106
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
106
Factors Affecting Protein-Drug Binding: Patient-Related Factors
45
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
45
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa
143
The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
The pKa of a...
143


